Related Experiment Video

Updated: Jun 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Regulation of TGF-beta signaling by Smad7

Xiaohua Yan1, Ziying Liu, Yeguang Chen

  • 1State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China.

Acta Biochimica Et Biophysica Sinica
|April 9, 2009
PubMed

Insights

Smad7 is an inhibitory protein that regulates transforming growth factor-beta (TGF-beta) signaling. Overexpression of Smad7 shows therapeutic potential against diseases like fibrosis and cancer.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Immunology

Background:

  • Transforming growth factor-beta (TGF-beta) is a cytokine controlling cell growth, differentiation, migration, and immune response.
  • TGF-beta signaling classically involves Smad proteins activated by cell surface receptors (TbetaRII, ALK5/TbetaRI).
  • TGF-beta also activates other pathways like MAPK and PI3K, and its signaling is tightly regulated.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of TGF-beta signaling, focusing on inhibitory Smads.
  • To investigate the role of Smad7 in negative feedback loops and its interactions within signaling pathways.
  • To explore the therapeutic potential of Smad7 in diseases associated with TGF-beta pathway deregulation.

Main Methods:

  • Analysis of Smad6 and Smad7 interactions with TGF-beta/BMP signaling components.
  • Investigation of Smad7's role in recruiting ubiquitin E3 ligases (Smurf1/2) for receptor degradation.
  • Examination of Smad7's nuclear interactions with transcriptional repressors and Smad-DNA complexes.
  • Review of studies linking Smad7 deregulation to human diseases and its therapeutic applications.

Main Results:

  • Inhibitory Smads (Smad6, Smad7) act as key negative regulators of TGF-beta/BMP signaling.
  • Smad7 blocks R-Smad phosphorylation by forming complexes with activated type I receptors.
  • Smad7 recruits ubiquitin ligases, leading to receptor degradation and inhibiting nuclear signaling.
  • Smad7 deregulation is linked to fibrosis, inflammation, and carcinogenesis; its overexpression counteracts these effects.

Conclusions:

  • Smad7 is a critical negative regulator of TGF-beta signaling through multiple mechanisms.
  • Smad7 plays a role in the crosstalk between TGF-beta and other signaling pathways.
  • Smad7's ability to antagonize TGF-beta-mediated pathologies suggests significant therapeutic potential.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...